Behandling af våd aldersrelateret makuladegeneration med vaskulaer endotel vaekstfaktorhaemmer. Gennemgang af et Cochrane-review
Engelsk titel: Treatment of wet age-related macular degeneration with vascular endothelial growth factor. A survey of a Cochrane review
Läs online
Författare:
Bloch SB
;
Larsen M
Email: sabrbl01@glo.regionh.dk
Språk: Dan
Antal referenser: 9
Dokumenttyp:
Översikt
UI-nummer: 09111939
Sammanfattning
This evaluation of a Cochrane-review including five clinical trials of good methodological quality indicates that the antiangiogenic therapeutic agents, pegaptanib and ranibizumab, are effective treatment strategies for neovascular Age-Related Macular Degeneration (AMD). The review does not include a direct comparison or an indirect statistical comparison between the two antiangiogenic agents. In clinical practice ranibizumab compared to pegaptanib is the drug of choice because of cost-utility analysis and the number of patients gaining visual acuity.